www.medtalks.eu 2018-08-30T07:00:11+00:00 daily 1 www.medtalks.eu/1e-nationale-cancer-survivorship-symposium-2016-late-effecten-op-cognitie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/1e-nationale-cancer-survivorship-symposium-2e-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/1e-nationale-cancer-survivorship-symposium-de-rol-van-de-huisarts 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/1e-nationale-cancer-survivorship-symposium-gevolgen-voor-fertiliteit 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/1e-nationale-cancer-survivorship-symposium-late-cardiovasculaire-effecten 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/1e-nationale-cancer-survivorship-symposium-prof-oeffinger-prof-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/1e-nationale-cancer-survivorship-symposium-terugkeer-naar-werk 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/1e-nationale-cancer-survivorship-symposium-vermoeidheid 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-kos-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschap-symposium 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anette-pet 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anette-pet 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anette-pet 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anette-pet 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anette-pet 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anette-pet 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anette-pet 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anne-may-yvonne-wengstrom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anne-may-yvonne-wengstrom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anne-may-yvonne-wengstrom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anne-may-yvonne-wengstrom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anne-may-yvonne-wengstrom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anne-may-yvonne-wengstrom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-anne-may-yvonne-wengstrom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annelies-bos 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annelies-bos 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annelies-bos 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annelies-bos 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annelies-bos 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annelies-bos 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annelies-bos 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annette-berendsen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annette-berendsen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annette-berendsen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annette-berendsen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annette-berendsen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annette-berendsen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-annette-berendsen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-bert-van-leeuwen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-corien-eeltink 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-corien-eeltink 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-corien-eeltink 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-corien-eeltink 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-corien-eeltink 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-corien-eeltink 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-corien-eeltink 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-ellen-kampman 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-ellen-kampman 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-ellen-kampman 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-ellen-kampman 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-ellen-kampman 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-ellen-kampman 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-ellen-kampman 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-janine-nuver 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-janine-nuver 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-janine-nuver 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-janine-nuver 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-janine-nuver 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-janine-nuver 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-janine-nuver 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-joke-korevaar 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-joke-korevaar 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-joke-korevaar 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-joke-korevaar 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-joke-korevaar 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-joke-korevaar 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-joke-korevaar 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-vivian-engelen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-vivian-engelen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-vivian-engelen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-vivian-engelen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-vivian-engelen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-vivian-engelen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/3e-nationale-kankeroverleverschapsymposium-vivian-engelen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/Oncology-nl 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/Ophthalmology-nl 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/aacr-2018-celvrij-dna-in-de-urine-als-biomarker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/aacr-2018-durvalumab-en-tremelimumab-bij-gemetastaseerd-blaascarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/aacr-2018-highlights-prostaatkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/aacr-2018-il-15-agonist-bij-non-hodgkin-lymfoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/aacr-2018-nieuw-bispecifiek-antilichaam-egfr-en-pd-l1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/aacr-2018-nivolumab-bij-gemetastaseerd-hoofd-halskanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/aacr-2018-tlr9-agonist-met-pembrolizumab-bij-gevorderd-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/aacr2018 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/acutelymfatischeleukemie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/alk2018 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/amsterdam-retina-debate 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/arvo-2017-diabetisch-macula-oedeem 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/arvo-2017-highlight-genetische-factoren-en-omgevingsinvloeden 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/arvo-2017-highlight-interviews 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/arvo-2017-highlight-leeftijdsgebonden-maculadegeneratie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/arvo-2017-highlight-overige-retina-aandoeningen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/arvo-2018-highlight-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/arvo-2018-highlight-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/arvo-2018-highlight-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2012-oncologie-journaal-03-06-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2012-oncologie-journaal-04-06-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2012-oncologie-journaal-05-06-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2012-oncologie-journaal-06-06-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2013-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2013-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2013-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2015-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2015-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2015-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2015-journaal-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2015-oncologie-journaals 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2016-oncologie-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2016-oncologie-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2016-oncologie-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2016-oncologie-journaals 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-calm-project-psychotherapie-bij-gevorderd-kanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-kwaliteitsregistratie-in-de-nederlandse-hoofd-hals-oncologische-zorg 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-meta-analyse-prognostische-en-predictieve-factoren-bij-gevorderd-maag-oesofaguscarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-neoadjuvante-chemotherapie-bij-duale-her2-blokkade 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-oncologie-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-oncologie-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-oncologie-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-oncologie-journaal-4-deel-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-oncologie-journaal-4-deel-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-oncologie-journaals 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-portec-3-trial-bij-endometriumcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-prognose-van-jonge-vrouwen-met-borstkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-spiermassaverlies-bij-gemetastaseerd-colorectaal-carcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-top-3-nieuws-voor-ge-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-top-3-nieuws-voor-hersentumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-top-3-nieuws-voor-prostaatcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-top-3-nieuws-voor-sarcomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-tumor-debulking-bij-gemetastaseerd-coloncarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2017-voorspellende-waarde-van-fdg-pet-voor-respons-op-cetuximab-bij-mcrc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-correlatie-nivolumab-exposure-en-respons 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-cytoreductieve-nefrectomie-bij-rcc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-externe-validatie-ajcc-criteria-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-genetisch-landschap-van-het-prostaatcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-impact-kurkuma-op-tamoxifen-metabolisatie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-lymfeklier-irradiatie-in-borstkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-oncologie-journaal-gastro-intestinale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-oncologie-journaal-gynaecologische-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-oncologie-journaal-longcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-oncologie-journaal-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-oncologie-journaal-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-oncologie-journaal-uro-genitale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-rechallenge-met-bevacizumab-voor-ovariumcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-resultaten-van-de-tailorx-studie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-top-3-nieuws-ge-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-top-3-nieuws-niercelcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-2018-top-3-nieuws-sarcomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-adjuvante-rt-na-cystectomie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-atezolizumab-in-mucc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-blaassparende-behandeling-bij-ouderen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-durvalumab-bij-mucc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-genomica-van-radioresistente-pca 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-internationaal-discussieprogramma-prostaat-en-blaaskanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-keynote-052 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-patientselectie-voor-docetaxelbehandeling 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-radiotherapie-versus-prostatectomie-bij-gleason-9-10-pca 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-rcc-journaal-posterinterviews-testiscarcinoomdebat 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-rcc-oncologie-journaal 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-recardo-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-tee-bij-neoadjuvante-behandeling-van-ucc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2017-testiscarcinoomdebat 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2018-niercelcarcinoom-journaal 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2018-oligo-progressie-bij-mrcc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2018-progressie-na-io-combinatietherapie-mrcc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-gu-2018-pros-en-hrqol-van-latitude 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-oncologie-journaal-aflevering-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-oncologie-journaal-aflevering-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-oncologie-journaal-aflevering-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/asco-oncologie-journaal-aflevering-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ascoam2018 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-highlight-1-hemofilie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-highlight-2-hemofilie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-highlight-2-hemophilia 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-highlight-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-oncologie-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-oncologie-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-oncologie-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-panel-discussie-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2012-panel-discussie-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2013-magazine-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2013-magazine-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2015-ann-janssens-cll-highlights 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2015-hemato-oncologie-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2015-hemato-oncologie-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2015-hemato-oncologie-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2015-michel-delforge-mm-highlights 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2017-hemato-oncologie-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2017-hemato-oncologie-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2017-hemato-oncologie-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2017-interview-john-seymour 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2017-interview-maria-victoria-mateos 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2017-interview-simona-soverini 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash-2017-interview-tim-grob 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ash_duplicate_1524144556 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/behandelvraagstukken-bij-de-1e-en-2e-lijns-behandeling-van-het-gemetastaseerd-heldercellig-niercelcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/belgium 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/benigne-levertumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/bijwerkingenmanagement-bij-de-behandeling-van-mrcc-met-targeted-therapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/bijwerkingenmanagement-bij-de-behandeling-van-mrcc-met-targeted-therapie-deel-1-patienten-aan-het-woord 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/bijwerkingenmanagement-bij-de-behandeling-van-mrcc-met-targeted-therapie-deel-2-het-verpleegkundig-perspectief 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/blaascarcinoom_duplicate_1522443199 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/chicago-schier-special-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/chicago-schier-special-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/chirurgie-bij-leeftijdsgebonden-maculadegeneratie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/chronischehepatitis 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/cml-moleculaire-monitoring 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/cml-wat-u-dient-te-weten 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/colofon-nl 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/compilatie-asco-2012-oncologie-tv-journaals 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/consensus-definitions-and-recommendations-for-iti 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/cookies 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/developments-in-neoadjuvant-breast-cancer-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/diffuusgrootcelligbcellymfoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/drieluik-crpc-1-2-crpc-in-de-praktijk 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/drieluik-crpc-1-afl-1-castratieresistentie-en-de-behandelopties 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/drieluik-crpc-2-1-perspectieven-pre-chemo-nieuwe-therapieopties 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/drieluik-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/drieluikmammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eahad-2012 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eahad-2016-highlight-1-ziekte-van-von-willebrand 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eahad-2016-highlight-2-hemofilie-a 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eahad-2016-highlight-3-musculoskeletale-complicaties 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eahad-2016-highlight-4-onderzoek-beleid-rondom-ehl-moleculen-ggz 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eahad-2016-highlight-interviews 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2013-dr-gerhardt-attard 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2013-dr-timothy-perren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2013-prof-alan-horwich 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2013-prof-caroline-robert 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2013-prof-dr-john-haanen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2013-prof-giuseppe-giaccone 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2013-prof-jonathan-ledermann 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-live-sessie-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-live-sessie-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-live-sessie-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-live-sessie-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-oncologie-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-oncologie-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-oncologie-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-oncologie-journaal-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-oncologie-journaals 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-studietuin-1-behandeling-borderline-irresectabel-recidief-rectumcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-studietuin-2-one-stage-chirurgie-voor-hepatogeen-gemetastaseerd-crc-rfa-versus-resectie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecc-2015-studietuin-3-resistentiepatroon-cabazitaxel-na-enzalutamide-abiraterone-bij-mcrpc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecco-2017-borstkanker-systemische-therapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecco-2017-highlight-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecco-2017-highlight-kanker-overleverschap 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecco-2017-highlight-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecco-2017-highlight-urogenitale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ecco-2017-highlights-borstkanker-locale-therapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-17-juni 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-18-juni 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-2012-oncologie-journaal-18-juni 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-2016-highlight-1-mpn 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-2016-highlight-2-chronische-leukemie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-2016-highlight-3-lymfomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-2016-highlight-4-aml-mds 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-2016-highlight-5-multipel-myeloom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/eha-2016-highlight-interviews 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/ehainreview2018 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en 2018-08-30T07:00:11+00:00 daily 1 www.medtalks.eu/en/2016-gu-cancers-symposium-news-program 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/Hematology-en 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/en/Internal-medicine 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/en/Oncology-en 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/en/Ophthalmology-en 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/en/abc2-2013-endocrine-sensitive-breast-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/abc2-2013-her2-positive-breast-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/abc2-2013-locally-advanced-breast-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/abc2-2013-triple-negative-breast-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ablation 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/about-medtalks 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/acc-2014-clinical-studies 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/acc-2014-exercise-and-sports 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/acc-2014-pulmonary-embolism 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/acc-2014-syncope 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/activity-and-exercise-and-cardiovascular-health 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/af-and-stroke 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/af-in-the-elderly 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-2013-breast-cancer-program-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-2013-breast-cancer-program-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-2013-chicago-in-the-mountains-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-2013-chicago-in-the-mountains-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-2013-chicago-in-the-mountains-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-2018-rechallenge-with-bevacizumab-in-ovarian-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-2018-results-of-the-tailorx-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-adjuvant-radiotherapy-after-cystectomy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-atezolizumab-in-mucc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-bladder-sparing-treatment-in-older-patients 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-discussion-program-on-prostate-and-bladder-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-durvalumab-in-advanced-ucc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-genomics-of-radioresistant-pca 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-identification-of-early-docetaxel-candidates-in-pca 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-keynote-052 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-rcc-news 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-recardo-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-rt-versus-surgery-in-gleason-9-10-pca 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-tee-during-neoadjuvant-chemotherapy-for-ucc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2017-testicular-cancer-debate-summary 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2018-oligoprogressive-mrcc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2018-progression-after-io-combination-regimens-mrcc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2018-pros-and-hrqol-of-latitude 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/asco-gu-2018-renal-cell-carcinoma-news-program 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2011-heamatology-journal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2011-hematology-journal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2011-hematology-journal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2012-hematology-news-program-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2012-hematology-news-program-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2012-hematology-news-program-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2012-highlight-1-hemophilia 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2012-highlight-1-thrombose 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2012-highlight-1-trombosis 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2013-anticoagulant-and-antithrombotic-therapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2013-highlight-hemophilia 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2013-prevention-and-management-of-vt-disease 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2013-trials-and-cohort-studies 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2014-highlight-1-multiple-myeloma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2014-highlight-2-lymphoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2014-highlight-3-leukemia 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ash-2014-interview-dr-saad-usmani 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/atrial-fibrilation-and-anticoagulants-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/atrial-fibrillation-and-anticoagulants-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/belgium 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/brugada-and-long-qt-syndrome 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/clinical-updates-from-the-eha-2017-part-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/clinical-updates-from-the-eha-2017-part-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/colofon_duplicate_1521705976 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/compilation-of-the-2013-ectrims 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/cookies 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/cosmos-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/drugs-and-cardiac-disease 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/e-learning-quarterly-focus-on-hemato-oncology-highlights-in-aml-2018 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eahad-2016-highlight-1-von-willebrand-disease 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eahad-2016-highlight-2-hemophilia-a 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eahad-2016-highlight-3-musculoskeletal-complications 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ebcc-2014-genomic-segmentation 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ebcc-2014-imaging 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ebcc-2014-local-therapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ebcc-2014-neoadjuvant-therapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ebcc-2014-radiotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ebcc-2014-screening 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ebcc-2014-systemic-treatment 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ecc-2013-dr-james-larkin 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ecc-2013-highlights-of-dr-gerhardt-attard-on-prostate-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ecc-2013-highlights-of-dr-james-larkin-on-melanoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ecc-2013-highlights-of-dr-timothy-perren-on-gynaecological-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ecc-2013-highlights-of-prof-alan-horwich-on-prostate-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ecc-2013-highlights-of-prof-caroline-robert-on-melanoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ecc-2013-highlights-of-prof-jonathan-ledermann-on-gynaecological-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ecc-2013-prof-giuseppe-giaccone-on-lung-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ectrims-2013-interview-series-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ectrims-2013-interview-series-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ectrims-2013-interview-series-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ectrims-2013-news-program-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ectrims-2013-news-program-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ectrims-2013-news-program-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eha-2012-news-program-16-06-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eha-2012-news-program-18-06-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eha-2012-news-program-june-16 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eha-2012-news-program-june-17 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eha-2012-news-program-june-18 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eha-2014-news-report-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eha-2014-news-report-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/eha-2014-news-report-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/esmo-2017-in-depth-ifct-0302-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/esmo-2017-in-depth-keynote-040-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/esmo-2017-in-depth-neoadjuvant-chemotherapy-in-cervical-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/esmo-2017-in-depth-range-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/esmo-2017-in-depth-tonic-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/extra-edition-eha-2014-news-report-multiple-myeloma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/faqs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/gender-differences 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/gu-cancers-symposium-2015-brussels 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/hematology-tv-2012 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/hemostasis-antithrombotic-therapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/interview-dr-gunnar-folprecht 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/isth-news-thrombosis-new-developments 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/ketogenic-diet-guidelines-for-infants-with-refractory-epilepsy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/login 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/management-in-af 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/medtalks-general-en 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/en/new-developments-in-hcc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/new-developments-in-hcv 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/new-insights 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/new-molecules-for-hcv 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/noacs-doacs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/noacs-in-general 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/oncologie-journal-3-7-july 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/oncology-news-program-at-genitourinary-cancers-symposium-2015 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/onkologievirtuos-2014-mammakarzinom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/oral-anticoagulation 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/overview-of-abc2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/overview-of-venicearrhythmias-2013 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/pediatric-hereditary-and-congenital-aspects 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/pre-wfh-congress-program 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/prevention-in-af 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/privacy-statement 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/publication-update-on-metastatic-melanoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/quarterly-focus-hemato-oncology-highlights-aml 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/quarterlybreastcancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/quarterlygu 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/quarterlygu2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/register 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/risk-and-management-of-major-bleeding 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/risk-profile-and-methods 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2012-breast-cancer-program-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2012-news-program-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-adjuvant-paclitaxel-and-trastuzumab 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-breastcancer-screening 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-episode-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-episode-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-episode-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-episode-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-neo-adjuvant-combination-therapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-new-drug-combination-for-metastatic-breast-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-surgery-and-radiation-after-chemotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-targeting-multiple-signaling-pathways 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2013-trastuzumab-biomarker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2014-matthew-ellis 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2015-dr-luc-dirix-about-the-first-results-on-anti-pdl1-avelumab 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2015-prof-gunter-von-minckwitz-about-the-geparsixto-study-results-on-survival 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/sabcs-2015-prof-nadia-harbeck-on-the-wsg-adapt-studies-for-er-her-and-triple-negative-breast-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/september-quarterly-focus-highlights-in-hodgkin-lymphoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/stroke-prevention-and-anticoagulation 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/terms_duplicate_1521705976 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/treatment-considerations 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/trial-update 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/trials-and-af 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/update-on-interventions-and-treatment-options 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/vaccination-hepatitis-b 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wclc-2011-interview-doctor-turrisi 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wclc-2011-interview-john-minna 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wcm-2017-highlights-biomarker-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wcm-2017-highlights-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wcm-2017-highlights-screening-organization 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wcm-2017-highlights-surgery 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2012-david-page 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2012-highlight-13-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2012-journaal-1-mark-skinner 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2012-journal-17-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2012-journal-19-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2012-journal-20-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2012-thomas-hilberg 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2014-highlights 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-2014-highlights-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/en/wfh-award-ceremony 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2012-oncologie-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2012-oncologie-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2012-oncologie-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2014-carien-creutzberg 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2014-interview-justine-kuiper 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2014-interview-rob-van-kruijsdijk 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2014-interview-tonneke-beijers 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2014-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2014-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2014-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2014-winette-van-der-graaf 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2016-highlights-borstkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2016-highlights-colorectaal-carcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2016-highlights-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2016-highlights-niet-kleincellig-longcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2016-highlights-ovariumcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2016-highlights-urogenitale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-highlights-gynaecologische-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-highlights-hoofd-halstumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-highlights-longkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-highlights-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-highlights-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-highlights-niercelcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-in-depth-ifct-0302-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-in-depth-keynote-040-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-in-depth-neoadjuvante-chemotherapie-bij-het-cervixcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-in-depth-range-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo-2017-in-depth-tonic-trial 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/esmo2017 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2015-highlight-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2015-highlight-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2015-highlight-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2015-highlight-interviews 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2016-camiel-boon 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2016-caroline-klaver 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2016-eiko-de-jong 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2016-jan-van-meurs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2016-jean-francois-korobelnik 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2016-martin-siemerink 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2016-rudy-nuijts 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2016-sarit-lesnik-oberstein 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2017-highlight-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2017-highlight-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/euretina-2017-highlight-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/faqs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/fix-assays-results-and-their-relationship 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/geselecteerde-interviews-over-colorectaal-carcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/geselecteerde-interviews-over-colorectaal-carcinoom-deel-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/geselecteerde-interviews-over-maagkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/geselecteerde-interviews-over-pancreas-en-galwegcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/gu-cancers-symposium-ermelo 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/gu-symposium-2016-oncologie-journaal 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/hematology-nl 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/hepatitis-b-en-rna 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/highlight-interviews-vanaf-de-wfh-2018 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/highlights-isth-2011-25-july-2011 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/highlights-isth-2011-26-july-2011 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/highlights-isth-2011-27-july-2011 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/highlights-isth-2011-28-july-2011 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/highlights-isth-2011-29-july-2011 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/highlights-isth-2011-29-july-2011-pt1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/hodgkinlymfoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/hoofd-hals-carcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-melanomen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immuno-neoadjuvante-behandeling-van-msi-colorectale-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-in-first-line-treatment-of-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-of-bladder-cancer-urothelial-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/immunotherapy-treatment-dilemmas-in-renal-cell-carcinoma 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/insight-substudies-and-rise 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/insight-substudy-on-clinical-risk-factors 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/internal-medicine-nl 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/interview-han-van-krieken 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-hans-gelderblom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-john-haanen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-luis-paz-ares 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-martin-van-den-bent 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-neal-shore 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-prof-dr-freek-verheugt 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-prof-dr-stefan-sleijfer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-prof-fortunato-ciardiello 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-prof-volker-heinemann 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-sandra-de-bruijn 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-tanguy-seiwert 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-veranderingen-in-de-richtlijn-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/interview-zorg-bij-het-uitgezaaide-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-immuno-oncologie-update-seizoen-2-aflevering-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-immuno-oncologie-update-seizoen-2-aflevering-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-immuno-oncologie-update-seizoen-2-aflevering-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-update-seizoen-1-aflevering-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-update-seizoen-1-aflevering-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-update-seizoen-1-aflevering-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-update-seizoen-1-aflevering-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-update-seizoen-1-aflevering-5 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/io-update-seizoen-1-aflevering-6 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2013-journal-gene-therapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2013-journal-lifelong-prophylaxis 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2013-journal-new-developments 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2017-instellen-meten-van-dalspiegels-bij-langerwerkende-fviii-en-of-langerwerkende-fix-producten 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2017-nieuwe-behandelbenaderingen-bij-patienten-met-hemofilie-a-en-remmers 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2017-nieuwe-behandelingsmogelijkheden-voor-hemofilie-en-vwd-in-ontwikkeling 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2017-ontwikkelingen-op-het-gebied-van-vwd-en-zeldzame-stollingsstoornissen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2017-optreden-van-remmers-en-de-behandeling-met-iti-nu-en-in-de-toekomst 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-2017-pk-gestuurd-doseren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-news-hemophilia-and-cancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-news-hemophilia-and-cardiovascular-disease 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-news-inhibitors-in-hemophilia 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-toronto-2015-highlight-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-toronto-2015-highlight-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-toronto-2015-highlight-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-toronto-2015-highlight-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth-toronto-2015-highlight-5 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/isth2017 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/kankeroverleverschap-symposium-2017-beter-poli 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/kankeroverleverschap-symposium-2017-ervaringsverhaal 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/kankeroverleverschap-symposium-2017-later-poli 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/kankeroverleverschap-symposium-2017-onderzoek-naar-werkhervatting 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/kankeroverleverschap-symposium-2017-psychosociale-gevolgen-van-kanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/kankeroverleverschap-symposium-2017-traject-amp-regelgeving 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/leeftijdsgebonden-maculadegeneratie-maculadystrofie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/liquid-biomarker-in-advanced-nsclc-for-immunotherapy 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/login 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/mammacarcinoom-deel-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/measurement-of-anticoagulant-status-in-saliva 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/medtalks-general-nl 2018-08-30T07:00:11+00:00 daily 0.9 www.medtalks.eu/melanoom-van-het-oog 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/multipelmyeloom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/myelofibrose-nieuwe-ontwikkelingen-in-diagnostiek-en-behandeling 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-chronische-lymfatische-leukemie-cll 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-chronische-myeloide-leukemie-cml 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-drieluik-crpc-13-behandelissues-nader-bekeken 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-drieluik-crpc-22-coordinatie-van-de-zorgketen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-drieluik-crpc-23-kwaliteit-van-leven-het-patientperspectief 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-easl-2015-in-de-praktijk 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-eha-2016-in-review 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-gemetastaseerd-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-nsclc-2017 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-ontwikkelingen-in-de-behandeling-van-nsclc 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-parp-remming-bij-ovariumcarcinoom-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-post-isth 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-post-wfh-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-post-wfh-2016 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-rcc-1-discussiepunten-uit-de-dagelijkse-praktijk 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-terugblik-op-de-asco-sitc-2017 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-terugblik-op-esmo-2016 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-terugblik-op-wclc-2016 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-tweeluik-niercelcarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-update-richtlijn-nsclc-2015 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-vaccineren-casus-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-vaccineren-casus-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-vaccineren-voor-bedrijfsartsen-casus-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-vaccineren-voor-bedrijfsartsen-casus-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-visitatie-in-vogelvlucht 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nascholing-zorg-rondom-de-stervensfase 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nationale-cancer-survivorship-symposium-2016-presentaties 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/new-development-in-nash 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nieuw-gen-macula-pigment 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nieuwe-europese-privacyverordening 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nieuwe-richtlijn-prostaatcarcinoom-belangrijkste-veranderingen-voor-de-kliniek-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/nieuwe-techniek-complete-vitrectomie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/noacs-education 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/oncology-news-program-at-genitourinary-cancers-symposium-2015 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/oratie-prof-dr-miriam-koopman 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/over-medtalks 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/pd-l1-testing-in-lung-cancer-an-update 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/persoonlijke-genoomtesten-lmd 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/privacy-statement 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/prof-dr-henk-verheul-op-nieuwe-ontwikkelingen-bij-de-ge-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/programma-onderhandelen-medicatie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/promo-therapietrouw-in-tijden-van-targeted-therapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/prostaatcarcinoom_duplicate_1522443027 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/publicatie-update-over-het-gemetastaseerd-melanoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/quarterlyaml2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/quarterlybreastcancer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/quarterlygu 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/quarterlygu2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/quarterlyhemato-oncology-highlights-aml 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/quarterlyhodgkin 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/rcc2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/register 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/regorafinib-oncologie-nieuwsspecial-v3-fl8-resize512-800kbpsflv 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/resultaten-vivid-vista-trials 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/retina-symposium-2015-dme 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/richtlijn-colorectaal-carcinoom-en-colorectale-levermetastasen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/richtlijn-en-behandelplan-bij-doorbraakpijn 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/richtlijn-oncologische-revalidatie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabc-2017jonge-vrouwen-met-borstkanker-en-risico-op-terugkeer-van-ziekte-volgens-het-70-genen-profiel 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2012-oncologie-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2012-oncologie-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2012-oncologie-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2012-oncologie-journaal-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2013-aflevering-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2013-aflevering-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2013-aflevering-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2013-aflevering-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2013-alert-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2013-alert-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2013-alert-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2013-interview-dr-john-martens 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2014-annelotte-van-bommel 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2014-john-maduro 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2014-journaal-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2014-journaal-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2014-journaal-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2014-journaal-4 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2015-de-selectie-van-dr-gabe-sonke-mbt-het-her-2-positieve-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2015-de-selectie-van-dr-judith-kroep-mbt-het-hormoongevoelige-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2015-de-selectie-van-prof-dr-emiel-rutgers-mbt-lokale-therapie-en-chemotherapievraagstukken 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2015-de-selectie-van-prof-dr-sabine-linn-mbt-het-triple-negatieve-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2015-dr-luc-dirix-over-de-eerste-resultaten-met-anti-pdl1-avelumab-bij-borstkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2015-prof-gunter-von-minckwitz-over-de-geparsixto-studie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2015-prof-nadia-harbeck-en-de-wsg-adapt-studies-voor-er-her-en-triple-negatief-borstkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2016-borstkanker-chirurgie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2016-her2-positief-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2016-highlight-interviews 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2016-hormoongevoelig-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2016-imeneo 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2016-jonge-vrouwen-met-borstkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2016-triple-negatief-mammacarcinoom-chemotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-dose-dense-vs-traditionele-therapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-highlights-cdk4-6-remmers-voor-het-hormoongevoelige-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-highlights-her-2-positief-mammacarcinoom-immuuntherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-highlights-triple-negatief-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-highlights-vroegstadium-hormoongevoelig-mammacarcinoom 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-in-depth-acupunctuur-bij-aromataseremmer-geassocieerde-gewrichtsklachten 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-in-depth-arm-morbiditeit-bij-jonge-borstkanker-overlevers 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-in-depth-ebctcg-meta-analyse-adjuvante-dose-dense-chemotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-in-depth-impact-van-tijdelijke-ovariele-suppressie-op-behoud-van-fertiliteit 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-in-depth-prognostische-waarde-van-circulerende-tumorcellen-5-jaar-na-diagnose-borstkanker 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-ovariele-suppressie-en-fertiliteit 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-poster-acute-toxiciteit-bij-2-geaccelereerde-partiele-borstbestralings-technieken 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-2017-poster-de-pi3k-mapk-pathways-en-tamoxifen-benefit 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-journaal-1-2014 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-journaal-2-2014 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-journaal-3-2014 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs-journaal-4-2014 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/sabcs_duplicate_1524144528 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tango-project-immunotherapie-bij-longkanker-en-ngs 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/terms 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/testpublicatie-medtalks-root 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/therapietrouw-in-tijden-van-targeted-therapie-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tijd-voor-beraad 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tissue-factor-pathway-inhibitor 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/tumour-heterogeneity-and-immunotherapy-treatment-outcomes 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wcgi-2014-barcelona 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2015-interview-roy-herbst 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2015-interviewserie-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2015-interviewserie-lokale-therapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2015-interviewserie-systemische-therapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2016-highlights-radiotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2016-highlights-targeted-therapie-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2016-immunotherapie-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2016-targeted-therapie-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2016-update-screening 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-aaron-lisberg 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-anna-larissa-niemeijer 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-benjamin-besse 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-chisel-study 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-de-nieuwe-tnm-classificatie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-highlights-alk-positieve-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-highlights-dirk-de-ruysscher 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-highlights-egfr-positieve-tumoren 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-interview-bartomeu-massuti 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-jake-chabon 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-kamran-ali 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-martin-reck 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-the-elders-study 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-2017-vinicius-ernani 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-nieuws-in-drie-interviewseries 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-sydney-op-schier-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-sydney-op-schier-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclc-sydney-op-schier-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wclcinreview 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wcm-2017-highlights-biomarkers-immuuntherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wcm-2017-highlights-chirurgie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wcm-2017-highlights-immuuntherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wcm-2017-highlights-screening-organisatie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wcminreview 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/welke-patienten-komen-in-aanmerking-voor-behandeling-met-pd-1-immunotherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2012-highlight-11-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2012-highlight-12-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2012-journal-17-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2012-journal-18-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2012-journal-18-07-12-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2012-journal-19-07-12 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2014-highlight-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2014-highlight-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2014-highlight-5 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2014-highlight-6 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2014-highlight-7 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2018-3 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2018-factor-productwisselingen-en-remmervorming 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2018-genetische-profielen 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2018-gentherapie 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2018-gewrichtsschade 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-2018-management 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-congress-news-friday-16-july-part-1 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-congress-news-friday-16-july-part-2 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-congress-news-monday-12-july 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-congress-news-thursday-15-july 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-congress-news-tuesday-13-july 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh-congress-news-wednesday-14-july 2018-08-30T07:00:11+00:00 daily 0.6 www.medtalks.eu/wfh2018 2018-08-30T07:00:11+00:00 daily 0.6